When and Why Mounjaro Higher Doses Are Prescribed

The decision isn't about wanting more, it's about readiness

People often ask for a higher dose because they assume it will automatically mean faster results. The clinical picture is more considered than that. Your prescriber is looking at two things simultaneously: whether your body has tolerated the current dose well enough over at least four weeks, and whether the response (appetite change, weight trend) suggests you've reached what the medicine can do at this strength. If both boxes are ticked, stepping up makes sense. If side effects are still settling, it does not.

The 2.5mg starting pen exists solely to ease your system in. It is a tolerability step, not a therapeutic target. From there, each increase typically follows a four-week rhythm, moving in 2.5mg increments up to the 15mg maintenance dose. The evidence on higher doses of tirzepatide consistently shows that stronger appetite suppression and greater average weight loss tend to come with each step up the schedule, but the journey is individual. Some people do very well at 5mg or 7.5mg. Others need 15mg to get meaningful traction. That is what the titration process is designed to find out.

At nume, every repeat order (and every dose increase) is clinically re-reviewed before it is dispensed. Your next pen doesn't go out on the basis of a previous approval; a prescriber reads your current picture fresh each time.

What a higher dose of Mounjaro actually does differently

Tirzepatide works by activating two gut-hormone receptors: GLP-1, which most people have heard of, and GIP, which is less talked about but equally important. Together they reduce appetite, slow the rate at which food leaves your stomach, and affect how your brain registers fullness. At a higher dose, both pathways are engaged more strongly. The practical result for most people is that portions that felt manageable on 5mg become genuinely difficult to finish on 10mg or 12.5mg.

This isn't simply appetite suppression turning up a dial. The relationship between dose and weight loss is real but not linear for everyone. Some people experience a marked step-change moving from 7.5mg to 10mg; others find the difference subtler. What the SURMOUNT-1 trial showed (published in the New England Journal of Medicine) is that the 15mg group achieved average reductions of around 20–21% of body weight over 72 weeks, compared to roughly 15% at 5mg. That gap is clinically significant. But trial averages describe populations, not individuals.

Side effects tend to track with dose too. Nausea, loose stools, and indigestion are most common after a step-up and usually settle within a couple of weeks. Going too fast (skipping a step, or increasing before four weeks are up) raises the chance that GI symptoms become disruptive enough to make people stop treatment unnecessarily. Patience at each rung is protective, not passive. The NHS patient information for tirzepatide outlines the common side effects clearly and is worth reading before any dose change.

How the dose increase works in practice at a regulated pharmacy

When you place a repeat order with Mounjaro through a registered pharmacy, a GPhC-registered prescriber reviews your consultation before anything is dispensed. At nume, this happens the same working day. If your request includes a dose increase, the prescriber checks the evidence you've provided (current weight, duration at the previous dose, any side-effect concerns) before approving it. If something doesn't add up, they'll ask. That is clinical care, not bureaucracy.

Order by midday Monday to Friday and, once approved, your next pen ships the same day. DPD delivers it the next working day; you'll get a tracking notification to your phone, and the box arrives plain and unbranded. The pen itself is pre-filled (four weekly injections per KwikPen) and goes straight into the fridge door when it arrives. Storage should follow the guidance in the Patient Information Leaflet exactly; room-temperature windows are more limited than most people expect.

There is a useful question worth sitting with before requesting a higher dose: has the current dose had enough time to work? Four weeks is the minimum. If you're three weeks in and frustrated, that frustration is understandable, but the answer usually isn't a higher dose yet. It's finishing the current step. The evidence on whether higher doses work better is consistent, but it assumes each prior dose was given its full run. See also the cost context for Mounjaro if you're weighing up how each step fits into a longer treatment plan.

When a higher dose might not be the right move yet

A prescriber might hold your dose (or even suggest stepping back temporarily) if side effects are still significant, if you've recently had a GI illness, or if there are clinical reasons to be cautious. This is not the treatment failing. It is the titration working as designed.

There are also situations where the current dose is doing enough. Not everyone needs 15mg. If you are losing weight steadily, tolerating the medicine well, and feeling the appetite effect, your prescriber may advise staying where you are. The assumption that higher always means better is worth examining, it is true at a population level, but individual responses vary considerably. NICE's appraisal of tirzepatide, TA1026, provides the clinical framework prescribers work within, including the guidance that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed.

If you're unsure where you stand, that conversation belongs with a prescriber. Check your eligibility and start a free consultation with the nume clinical team, a real prescriber will look at your specific situation and advise on whether a dose increase is the right next step.